Clinical Trial Update: Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder [Phase 4]

View source ↗

Summary

A Phase 4 safety study comparing Depakote (divalproex sodium) to Lithium in African American patients with Bipolar Disorder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• DEPAKOTE (DIVALPROEX SODIUM)
• Lithium (Lithium carbonate)

Snippet

Sponsor: Lawson, William B., M.D., PhD, DFAPA | Conditions: Bipolar Disorder | Phase 4 | Status: WITHDRAWN